news
08-28-2017, 07:04 PM
The agency reported actions against a biotech company and two large stem cell clinics over unapproved treatments, a move it said was necessary to make way for speedier approval of legitimate therapies.
More... (https://www.nytimes.com/2017/08/28/health/fda-stem-cell.html?partner=rss&emc=rss)
More... (https://www.nytimes.com/2017/08/28/health/fda-stem-cell.html?partner=rss&emc=rss)